Literature DB >> 9068999

Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients.

T Scheeren1, P Radermacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9068999     DOI： 10.1007/s001340050309

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Primary pulmonary hypertension during pregnancy: A case report.

Authors:  Hanan B Albackr; Lateefa O Aldakhil; Alshaer Ahamd
Journal:  J Saudi Heart Assoc       Date:  2013-01-05

2.  Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.

Authors:  Mohammad Shoeb; Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-08-05       Impact factor: 7.376

Review 3.  The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients.

Authors:  E Christiaan Boerma; Can Ince
Journal:  Intensive Care Med       Date:  2010-09-02       Impact factor: 17.440

4.  Effects of prostacyclin on the early inflammatory response in patients with traumatic brain injury-a randomised clinical study.

Authors:  Marie Rodling Wahlström; Magnus Olivecrona; Clas Ahlm; Anders Bengtsson; Lars-Owe D Koskinen; Silvana Naredi; Magnus Hultin
Journal:  Springerplus       Date:  2014-02-18

5.  Do alterations in pulmonary vascular tone result in changes in central blood volumes? An experimental study.

Authors:  Jaap Jan Vos; J K Götz Wietasch; Andreas Hoeft; Thomas W L Scheeren
Journal:  Intensive Care Med Exp       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.